Requiring drug testing for individuals receiving office-based medication-assisted treatment

SB 515 Text

skip navigation

SENATE

PRESIDENT

SENATORS

COMMITTEES

VIDEO/AUDIO

DISTRICT MAPS

SENATE CLERK

SENATE RULES

HOUSE

SPEAKER

DELEGATES

COMMITTEES

VIDEO/AUDIO

DISTRICT MAPS

HOUSE CLERK

HOUSE RULES

HOUSE STAFF

JOINT

INTERIM COMMITTEES

LEGISLATIVE ADMINISTRATOR

LEGISLATIVE SERVICES DIVISION

PUBLIC INFORMATION

LEGISLATIVE AUTOMATED SYSTEMS DIVISION

LEGISLATIVE AUDITOR'S OFFICE

PERFORMANCE EVALUATION & RESEARCH DIVISION

POST AUDIT DIVISION

BUDGET DIVISION

REGULATORY AND FISCAL AFFAIRS DIVISION

CLAIMS COMMISSION

CRIME VICTIMS

RULE-MAKING REVIEW

SPECIAL INVESTIGATIONS

JUDICIAL COMP. COMMISSION

JOINT RULES

STAFF INFO

BILL STATUS

BILL STATUS

BILL TRACKING

STATE LAW

WEST VIRGINIA CODE

ACTS OF THE LEGISLATURE

CODE OF 1931

WV CONSTITUTION

US CONSTITUTION

REPORTS

AGENCY REPORTS

AGENCY GRANT AWARDS

PERFORMANCE EVALUATIONS

POST AUDITS

EDUCATIONAL

CITIZEN’S GUIDE

INTERNSHIP PROGRAM

PAGE PROGRAM

PUBLICATIONS

PHOTO GALLERY

CAPITOL HISTORY

HOW A BILL BECOMES LAW

CONTACT

SENATE ROSTER

HOUSE ROSTER

PUBLIC INFO.

NEWS RELEASES

HELPFUL LINKS

Introduced Version

Senate Bill 515 History

|
Email

Key:
Green
= existing Code.
Red
= new code to be enacted

WEST VIRGINIA LEGISLATURE
2026
REGULAR SESSION

FISCAL NOTE

Introduced
Senate Bill 515
By Senator Takubo
[Introduced January 20, 2026; referred
to the Committee on Health and Human Resources; and then to the Committee on Finance]
A BILL to amend the Code of West Virginia, 1931, as amended, by adding a new section, designated §16B-13-4a, relating to drug testing for individuals in an office-based, medication-assisted treatment program; and providing a schedule of drug tests.
Be it enacted by the Legislature of West Virginia:

Article 13. medication-assisted treatment PROGRAM licensing act.

§16B-13-4a. Drug testing during progression of treatment for substance use disorder.

(a) Upon being admitted as a patient to an office-based medication-assisted treatment program, the provider shall perform a comprehensive, definitive drug test.
(b) After this time and continuing for six weeks, a direct observation, definitive test must be performed every two weeks for six weeks.
(c) Once the patient moves into the stabilization phase of treatment, the patient shall undergo a direct observation, presumptive test every 45 days for one year while in treatment.
(d) Following the stabilization phase of treatment, the patient moves into the maintenance phase of treatment and during the maintenance phase of treatment shall undergo a direct observation, presumptive test every six months thereafter until discharge from the program.
(e) At any point the provider wants to assess compliance, the patient must be willing to produce a direct observation presumptive or definitive test upon the provider request.
(f) Unexpected findings from presumptive test issued pursuant to this section may be subject to confirmation of results or testing of additional substances of concern for which presumptive testing is inadequate or unavailable by a definitive testing method.

NOTE: The purpose of this bill is to require drug tests for individuals receiving office-based medication-assisted treatment.
Strike-throughs indicate language that would be stricken from a heading or the present law and underscoring indicates new language that would be added.

Bill Status
|

Bill Tracking
|

Legacy WV Code
|

Bulletin Board
|

District Maps
|

Senate Roster
|

House Roster
|

Live
|

Blog
|

Jobs
|

Links
|

Home

This Web site is maintained by the
West Virginia Legislature's Office of Reference & Information.
|
Terms of Use
|

Webmaster
| © 2026 West Virginia Legislature **

Print On Demand

Name:

Email:

Phone: